Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.

TitleConnecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.
Publication TypeJournal Article
Year of Publication2022
AuthorsYu EYoung, Cheung N-KV, Lue NF
JournalJ Hematol Oncol
Volume15
Issue1
Pagination117
Date Published2022 Aug 27
ISSN1756-8722
KeywordsCell Differentiation, Cell Proliferation, Child, Humans, Neuroblastoma, Telomerase, Telomere, Telomere Homeostasis
Abstract

A cardinal feature that distinguishes clinically high-risk neuroblastoma from low-risk tumors is telomere maintenance. Specifically, neuroblastoma tumors with either active telomerase or alternative lengthening of telomeres exhibit aggressive growth characteristics that lead to poor outcomes, whereas tumors without telomere maintenance can be managed with observation or minimal treatment. Even though the need for cancer cells to maintain telomere DNA-in order to sustain cell proliferation-is well established, recent studies suggest that the neural crest origin of neuroblastoma may enforce unique relationships between telomeres and tumor malignancy. Specifically in neuroblastoma, telomere structure and telomerase activity are correlated with the adrenergic/mesenchymal differentiation states, and manipulating telomerase activity can trigger tumor cell differentiation. Both findings may reflect features of normal neural crest development. This review summarizes recent advances in the characterization of telomere structure and telomere maintenance mechanisms in neuroblastoma and discusses the findings in the context of relevant literature on telomeres during embryonic and neural development. Understanding the canonical and non-canonical roles of telomere maintenance in neuroblastoma could reveal vulnerabilities for telomere-directed therapies with potential applications to other pediatric malignancies.

DOI10.1186/s13045-022-01337-w
Alternate JournalJ Hematol Oncol
PubMed ID36030273
PubMed Central IDPMC9420296
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587